Science
Choose a subcategory:
BROOMFIELD, Colo., March 17/ PRNewswire-FirstCall/- Ball Corporation announced today that it priced an underwritten public offering of $ 500 million, $ 50 million more than previously announced, in aggregate principal amount of 6.75 percent
Previously, Mr. Rothwell had served as President, Polymer Group from 2001 to 2002; President, Chemicals Group from 1999 to 2001; and Senior Vice President and Chief Financial Officer from 1998 to 1999, in each case for Eastman Chemical Comp
Ltd.); Countrymark Cooperative; Dominion Transmission, Inc.; The Dow Chemical Company; Dow Corning Corporation; Eastman Chemical Company; EQ Northeast, Inc.; Evonik Degussa Corporation; ExxonMobil Chemical; Glacial Lakes Energy; Granite Fal
Deutsche Bank Securities Inc., Jefferies Finance LLC, Citigroup Global Markets Inc., HSBC Securities ( USA) Inc. and J.P. Morgan Securities Inc. are acting as joint lead arrangers and joint bookrunners on the refinancing.
Homeowners, who have used this solution to permanently solve their Chinese drywall problem, opened their homes and welcomed neighbors, builders, real estate agents, and many others at an open house and technology demonstration held on Wedne
The Soap and Detergent Association ( www. cleaning101. com), the Home of the U.S. Cleaning Products Industry ( ( R)), is a one-hundred plus member trade association representing the $ 30 billion U.S. cleaning products market.
Reliv International, Inc., based in Chesterfield, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements.
Iosil Energy Corporation Secures First Close on $13.5M in Equity Financing to Build Pilot Manufactur
ALBUQUERQUE, N.M., March 17/ PRNewswire/- Iosil Energy Corporation ( " Iosil"), an innovator in the production of high-purity solar grade polysilicon for the photovoltaic industry, announced today that it has secured $ 13.5 million in equit
CMAI Announces End of Registration for 2010 World Petrochemical Conference and CMAI to Present at th
With the key product and business managers from around the world in attendance, this forum has proven to be a valuable prelude to the annual International Petrochemical Conference- National Petrochemical & Refiners Association ( NPRA).
PolyOne to Participate in the BB&T Capital Markets Commercial and Industrial One-on-One Conference o
CLEVELAND, March 17/ PRNewswire-FirstCall/- PolyOne Corporation, a premier global provider of specialized polymer materials, services and solutions, announced today that Stephen D. Newlin, chairman, president and chief executive officer, an
Arsenal Capital Partners Announces Definitive Agreement To Sell Genovique Specialties Corporation To
NEW YORK, March 17/ PRNewswire/- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market specialty industrial, healthcare and financial services companies, today announced that it has entered int
A Podcast is available at: http:// www.presseportal. de/pm/ 16344/1579482/ basf_ se Editorial contact: For the UK: BASF plc Chris Wilson Corporate Communications Phone:+ 44-161- 488-5616 Fax:+ 44-161- 488-4133 E-Mail: chris. wilson@ basf. c
Field ID Continues Its Commitment to Customer Service and Training by Launching the Field ID Univers
" With the launch of the Field ID University we are excited to provide a customizable, flexible and continuous way for our customers to get the most out of Field ID", said Matthew Paterson, Senior Business Analyst at N4 Systems.
( PINKSHEETS: AWSL) is pleased to announce that it is acquiring a 60% interest in Aim Global Energy Inc., ( AIM) the manufacturer of leading edge, high-yield converter/inverter ( CIT) technology used in AWSL's high yield Renewable Energy sy
Previously, Mr. Rothwell had served as President, Polymer Group from 2001 to 2002; President, Chemicals Group from 1999 to 2001; and Senior Vice President and Chief Financial Officer from 1998 to 1999, in each case for Eastman Chemical Comp
BioteQ Environmental Technologies Inc. Consolidated Statement of Cash Flows ( Unaudited) For the year ended December 31, 2009 2009 2008 $ $ Cash flows from ( used in) operating activities Loss for the year $ ( 4,693,951) $ ( 5,245,149) Item
The company reported net income of $ 0.68 million, or basic and diluted earnings per share of $ 0.09 for the year ended December 31, 2009 compared with net income of $ 1.7 million, or basic and diluted earnings per share of $ 0.22 and $ 0.2
The company reported net income of $ 0.68 million, or basic and diluted earnings per share of $ 0.09 for the year ended December 31, 2009 compared with net income of $ 1.7 million, or basic and diluted earnings per share of $ 0.22 and $ 0.2
Ltd.); Countrymark Cooperative; Dominion Transmission, Inc.; The Dow Chemical Company; Dow Corning Corporation; Eastman Chemical Company; EQ Northeast, Inc.; Evonik Degussa Corporation; ExxonMobil Chemical; Glacial Lakes Energy; Granite Fal
ZUG, Switzerland, March 17, 2010 ( GLOBE NEWSWIRE)- Transocean Ltd. today announced that Steven L. Newman, President & Chief Executive Officer of the company, will address attendees at the Howard Weil Energy Conference in New Orleans, LA. M
About Wild Brush Energy Inc. Wild Brush Energy Inc. is a diversified energy company whose goal is to identify and develop clean air energy producing alternatives.
About Wild Brush Energy Inc. Wild Brush Energy Inc. is a diversified energy company whose goal is to identify and develop clean air energy producing alternatives.
WPCS INTERNATIONAL INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME ( Unaudited) Three Months Ended Nine Months Ended January 31, January 31, 2010 2009 2010 2009 REVENUE $ 26,972,380 $ 25,323,422 $ 76,557,723 $ 82,3
Separately, IPO Desktops CHWM analyst report is available at: http:// www.gaskinsco. com/linkto- chwm. shtml About China Wi-Max Communications, Inc.: China Wi-Max Communications, Inc.
BOARD OF DIRECTORS AND OFFICERS Cooper's stockholders elected the following as members of the board of directors: A. Thomas Bender, chairman of the board of the Company; Allan E. Rubenstein, M.D., vice-chairman of the board and lead directo
Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs.
Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs.
Please see the Company's Annual Report on Form 10-K for the year ended December 31, 2009, as well as subsequent SEC filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties ass
Idaho Health Freedom Act Does Nothing to Tackle State's Health Care Crisis & Everything to Make it Worse
Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Dis
National Drug Code Product Description ( NDC) Lot Number Expiry Date ALIMTA FINJ 500MG X1 lyophilizedVIAL AM 00002-7623- 01 A671076 C 8/31/2011 CYMBALTA CAP 30MG X 30 BTL AM 00002-3240- 30 A643056 A 5/31/2012 CYMBALTA CAP 30MG X 30 BTL AM 0
Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Dis
National Drug Code Product Description ( NDC) Lot Number Expiry Date ALIMTA FINJ 500MG X1 lyophilizedVIAL AM 00002-7623- 01 A671076 C 8/31/2011 CYMBALTA CAP 30MG X 30 BTL AM 00002-3240- 30 A643056 A 5/31/2012 CYMBALTA CAP 30MG X 30 BTL AM 0
Cenpatico Behavioral Health of Arizona, LLC ( TM) ( Cenpatico) facilitates the delivery of mental health and substance abuse services to behavioral health recipients in the Arizona counties of Yuma, La Paz, Gila and Pinal.
CINCINNATI, March 17/ PRNewswire-FirstCall/- Kendle, a leading, global full-service clinical research organization, today announced that it has entered into a new $ 35 million secured revolving credit facility as of March 15, 2010 with JPMo
Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical tr
MediciNova Reports Positive Preliminary Results From a Phase Ib Clinical Trial of MN-221 in Moderate
Factors that may cause actual results or events to differ materially from those expressed or implied by these forward-looking statements, include, but are not limited to, the risks and uncertainties inherent in clinical trials and product d
Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical tr